Alphatec Holdings, Inc. reported a 43% increase in total revenue to $90 million for the third quarter of 2022. The company also saw a 53% growth in surgical revenue and $11 million in EOS revenue. There was also a significant improvement in adjusted EBITDA year-over-year and sequentially.
Total revenue grew 43% to $90 million, including surgical revenue growth of 53%.
EOS revenue reached $11 million.
Surgical volume increased by 32% and user base grew by 22% compared to the prior year.
Adjusted EBITDA margin increased by approximately 870 basis points compared to prior year and approximately 290 basis points sequentially.
The Company expects total revenue of $340 million for the fiscal year ended December 31, 2022, in line with the 40% full-year growth rate previewed in conjunction with the release of preliminary third quarter financial results. This includes surgical revenue growth of approximately 39% and $46 million of EOS revenue.
Analyze how earnings announcements historically affect stock price performance